News
05-11-2017, 04:30 AM
Tamoxifen, a selective estrogen receptor modulator, is the gold standard for endocrine treatment of estrogen-receptor positive breast cancer.
More... (http://www.news-medical.net/news/20170511/Breast-cancer-drug-offers-protection-against-obesity-related-metabolic-disorders.aspx)
More... (http://www.news-medical.net/news/20170511/Breast-cancer-drug-offers-protection-against-obesity-related-metabolic-disorders.aspx)